Treatment of psoriatic nails with indigo naturalis oil extract: A non-controlled pilot study

Dermatology

Volumn 223, Issue 3, 2011, Pages 239-243

  Lin, Yin Ku ^a,b   See, Lai Chu ^c,d   Chang, Ya Ching ^a   Huang, Yu Huei ^a   Chen, Jiun Liang ^a   Tsou, Teng Cheng ^a   Leu, Yann Lii ^e   Shen, Yu Ming ^c,d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b School of Traditional Chinese Medicine   (Taiwan)

^c Institute of Clinical Pharmacy and Pharmaceutical Sciences   (Taiwan)

^d Molecular Medicine Research Center   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Indigo naturalis; Indirubin; Modified target Nail Psoriasis Severity Index; Nail Psoriasis Severity Index; Psoriatic nails

Indexed keywords

INDIGO NATURALIS OIL EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FINGER NAIL; HUMAN; HYPERKERATOSIS; MALE; NAIL DISEASE; NAIL PSORIASIS; ONYCHOLYSIS; PAIN; PILOT STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; INDOLES; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; NAIL DISEASES; OILS; PILOT PROJECTS; PSORIASIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84355162076     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000333362     Document Type: Article

References (14)

1. Augustin M, Reich K, Blome C, Schafer I, Laass A, Radtke MA: Nail psoriasis in Germany: epidemiology and burden of disease. Br J Dermatol 2010; 163: 580-585.
2. Lin YK, Wong WR, Chang YC, Chang CJ, Tsay PK, Chang SC, Pang JH: The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis. Dermatology 2007; 214: 155-161.
3. Lin YK, Chang CJ, Chang YC, Wong WR, Chang SC, Pang JH: Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis. Arch Dermatol 2008; 144: 1457-1464.
4. Lin YK: Indigo naturalis oil extract drops in the treatment of moderate to severe nail psoriasis: a small case series. Arch Dermatol 2011; 147: 627-629.
5. Rich P, Scher RK: Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003; 49: 206-212. (Pubitemid 36951265)
6. Parrish CA, Sobera JO, Elewski BE: Modification of the Nail Psoriasis Severity Index. J Am Acad Dermatol 2005; 53: 745-746, author reply 746-747.
7. Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY: Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007; 57: 1-27. (Pubitemid 46899261)
8. Rigopoulos D, Gregoriou S, Daniel CR III, Belyayeva H, Larios G, Verra P, Stamou C, Kontochristopoulos G, Avgerinou G, Katsambas A: Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment. Dermatology 2009; 218: 338-341.
9. Augustin M, Ogilvie A: Methods of outcomes measurement in nail psoriasis. Dermatology 2010; 221: 23-28.
10. Lin YK, Leu YL, Yang SH, Chen HW, Wang CT, Pang JH: Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component. J Dermatol Sci 2009; 54: 168-174.
11. Lin YK, Leu YL, Huang TH, Wu YH, Chung PJ, Su Pang JH, Hwang TL: Anti-inflammatory effects of the extract of indigo naturalis in human neutrophils. J Ethnopharmacol 2009; 125: 51-58.
12. Chang HN, Pang JH, Yang SH, Hung CF, Chiang CH, Lin TY, Lin YK: Inhibitory effect of indigo naturalis on tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human umbilical vein endothelial cells. Molecules 2010; 15: 6423-6435.
13. De Jong EM, Seegers BA, Gulinck MK, Boezeman JB, van de Kerkhof PC: Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology 1996; 193: 300-303.
14. McGonagle D, Palmou Fontana N, Tan AL, Benjamin M: Nailing down the genetic and immunological basis for psoriatic disease. Dermatology 2010; 221: 15-22.